Back to results
US 2016/0096903 A1Published application
Humanization of rabbit antibodies using a universal antibody framework
AssigneeESBATech, an Alcon Biomedical Research Unit LLC
InventorsLeonardo Jose Borras, David Urech
Life of this patent
Estimating the term…
Abstract
The present invention relates to an universal antibody acceptor framework and to methods for grafting non-human antibodies, e.g., rabbit antibodies, using a universal antibody acceptor framework. Antibodies generated by the methods of the invention are useful in a variety of diagnostic and therapeutic applications.
Claims21
An immunobinder comprising:
- (i) light chain CDR1, CDR2 and CDR3 from a donor lagomorph immunobinder and heavy chain CDR1, CDR2 and CDR3 from a donor lagomorph immunobinder;
- (ii) a variable human light chain framework;
- and
- (iii) a variable human heavy chain framework that is at least 85% identical to the sequence of SEQ ID NO:
- 4 and comprises a threonine (T) at position 24, alanine (A) or glycine (G) at position 56, threonine (T) or asparagine (N) at position 84, and leucine (L) or valine (V) at position 89 (AHo numbering).
2 more elements
A method of humanizing a rabbit immunobinder, the rabbit immunobinder comprising heavy chain CDR H1, CDR H2 and CDR H3 sequences and light chain CDR L1, CDR L2 and CDR L3 sequences, the method comprising:
- (i) grafting the rabbit CDR H1, CDR H2 and CDR H3 sequences into a human heavy chain acceptor framework that is at least 85% identical to the sequence of SEQ ID NO:
- 4 and that comprises a threonine (T) at position 24 (AHo numbering), alanine (A) or glycine (G) at position 56, threonine (T) or asparagine (N) at position 84, and leucine (L) or valine (V) at position 89 (AHo numbering), and
- (ii) grafting the rabbit CDR L1, CDR L2 and CDR L3 sequences into a human light chain acceptor framework, the human light chain framework having at least 85% identity to SEQ ID NO:2.
Dependencies are inferred from the claim text.